Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 12 - 01 tags : Cancer save search
Global Epigenetics Market Analysis Report 2022: Growing Prevalence of Cancer and Other Diseases Significantly Driving Growth
Published: 2022-12-01 (Crawled : 20:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.08%
H: 1.44%
C: 1.28%
global report growing cancer growth market
Taylor Morrison to Build and Donate Homes to Support Patients at Banner MD Anderson Cancer Center
Published: 2022-12-01 (Crawled : 20:00) - prnewswire.com
TMHC | $54.03 0.43% 0.0% 990K
|
Consumer Durables
|
| O: -2.37%
H: 3.1%
C: 1.9%
cancer
SELLAS Life Sciences’ CDK9 Inhibitor GFH009 Demonstrates Tumor Growth Inhibition in Small Cell Lung Cancer Murine Model
Published: 2022-12-01 (Crawled : 19:00) - biospace.com/
SLS | $1.505 6.74% 6.31% 1.6M
|
Health Technology
|
| O: 1.26%
H: 10.74%
C: 7.44%
gfh009 lung life cancer growth
Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope
Published: 2022-12-01 (Crawled : 15:00) - prnewswire.com
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: -0.34%
H: 1.12%
C: 0.05%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.07%
H: 1.06%
C: -0.37%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: -0.39%
H: 3.68%
C: 1.93%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: -0.33%
H: 3.0%
C: -0.33%
research therapeutics cancer ovarian cancer
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
LUCD | $0.7957 -0.8% -0.8% 70K
|
|
| O: -1.08%
H: 4.09%
C: 2.17%
PAVM | $1.95 -1.02% -1.03% 32K
|
Health Technology
|
| O: 0.0%
H: 2.66%
C: -0.01%
research diagnostics cancer lucid-ms
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
BIAF | $2.78 -4.47% -4.68% 140K
|
|
| O: 1.26%
H: 2.05%
C: 1.32%
research meeting cancer
Guardant Health to Showcase New Data at San Antonio Breast Cancer Symposium 2022 Demonstrating Utility of Its Blood Tests for Advanced-stage Breast Cancer Patients
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
GH M | $16.68 1.77% 1.74% 1.6M
|
Health Services
|
| O: 0.36%
H: 2.8%
C: -0.23%
blood breast health symposium cancer
Theralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
THER | $0.001 62.5% 1.9M
|
n/a
|
| O: 5.26%
H: 0.0%
C: -12.5%
theralink breast symposium cancer
Oncolytics Biotech® Receives FDA Fast Track Designation for the Treatment of Advanced/Metastatic Pancreatic Cancer
Published: 2022-12-01 (Crawled : 13:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 5.11%
H: 23.24%
C: 14.59%
biotech treatment fda designation cancer pancreatic fast track designation
Compugen's COM701 (anti-PVRIG) in Dual and Triple Combination Demonstrates Preliminary Anti-Tumor Activity and Immune Activation in Platinum Resistant Ovarian Cancer Patients
Published: 2022-12-01 (Crawled : 12:20) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 3.33%
H: 0.0%
C: -8.87%
com701 cancer ovarian cancer
COMPELLING PRECLINICAL DATA FOR KAZIA'S EVT801 PUBLISHED IN PEER-REVIEWED CANCER RESEARCH JOURNAL
Published: 2022-12-01 (Crawled : 12:20) - prnewswire.com
KZIA | $0.3522 2.32% 2.27% 270K
|
Health Technology
|
| O: 1.26%
H: 4.71%
C: 3.89%
evt801 research preclinical cancer
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.